AAAAAA

   
Results: 1-9 |
Results: 9
Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists
Authors: Barrow, JC Nantermet, PG Selnick, HG Glass, KL Ngo, PL Young, MB Pellicore, JM Breslin, MJ Hutchinson, JH Freidinger, RM Condra, C Karczewski, J Bednar, RA Gaul, SL Stern, A Gould, R Connolly, TM
Citation: Jc. Barrow et al., Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists, BIOORG MED, 11(20), 2001, pp. 2691-2696
Diaryl ether inhibitors of farnesyl-protein transferase
Authors: MacTough, SC DeSolms, SJ Shaw, AW Abrams, MT Ciccarone, TR Davide, JP Hamilton, KA Hutchinson, JH Koblan, KS Kohl, NE Lobell, RB Robinson, RG Graham, SL
Citation: Sc. Mactough et al., Diaryl ether inhibitors of farnesyl-protein transferase, BIOORG MED, 11(10), 2001, pp. 1257-1260
Ligands to the integrin receptor alpha(v)beta(3)
Authors: Duggan, ME Hutchinson, JH
Citation: Me. Duggan et Jh. Hutchinson, Ligands to the integrin receptor alpha(v)beta(3), EXPERT OP T, 10(9), 2000, pp. 1367-1383
Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors
Authors: Egbertson, MS Bednar, B Askew, BC Bednar, RA Brashear, K Breslin, MJ Duggan, ME Fisher, TE Halczenko, W Hutchinson, JH Ihle, N Prugh, JD Wai, JS Gould, RJ Hartman, GD
Citation: Ms. Egbertson et al., Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors, BIOORG MED, 10(17), 2000, pp. 1943-1948
Syntheses of 5-and 6-[2,3]-dihydrobenzofuran beta-amino acids
Authors: Coleman, PJ Hutchinson, JH Hunt, CA Lu, P Delaporte, E Rushmore, T
Citation: Pj. Coleman et al., Syntheses of 5-and 6-[2,3]-dihydrobenzofuran beta-amino acids, TETRAHEDR L, 41(31), 2000, pp. 5803-5806
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors
Authors: Frenette, R Hutchinson, JH Leger, S Therien, M Brideau, C Chan, CC Charleson, S Ethier, D Guay, J Jones, TR McAuliffe, M Piechuta, H Riendeau, D Tagari, P Girard, Y
Citation: R. Frenette et al., Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors, BIOORG MED, 9(16), 1999, pp. 2391-2396
Non-peptide fibrinogen receptor antagonists. 4(1). The synthesis of [H-3]L-756,568.
Authors: Hamill, TG Hutchinson, JH Brashear, KM Hartman, GD
Citation: Tg. Hamill et al., Non-peptide fibrinogen receptor antagonists. 4(1). The synthesis of [H-3]L-756,568., J LABEL C R, 42(6), 1999, pp. 605-609
N-arylpiperazinone inhibitors of farnesyltransferase: Discovery and biological activity
Authors: Williams, TM Bergman, JM Brashear, K Breslin, MJ Dinsmore, CJ Hutchinson, JH MacTough, SC Stump, CA Wei, DD Zartman, CB Bogusky, MJ Culberson, JC Buser-Doepner, C Davide, J Greenberg, IB Hamilton, KA Koblan, KS Kohl, NE Liu, DM Lobell, RB Mosser, SD O'Neill, TJ Rands, E Schaber, MD Wilson, F Senderak, E Motzel, SL Gibbs, JB Graham, SL Heimbrook, DC Hartman, GD Oliff, AI Huff, JR
Citation: Tm. Williams et al., N-arylpiperazinone inhibitors of farnesyltransferase: Discovery and biological activity, J MED CHEM, 42(19), 1999, pp. 3779-3784
Potent, non-thiol inhibitors of farnesyltransferase
Authors: Breslin, MJ deSolms, SJ Giuliani, EA Stokker, GE Graham, SL Pompliano, DL Mosser, SD Hamilton, KA Hutchinson, JH
Citation: Mj. Breslin et al., Potent, non-thiol inhibitors of farnesyltransferase, BIOORG MED, 8(23), 1998, pp. 3311-3316
Risultati: 1-9 |